Corcept Therapeutics (CORT) Other Working Capital Changes (2010 - 2026)

Corcept Therapeutics has disclosed Other Working Capital Changes across 17 years of filings, most recently posting -$4.7 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$4.7 million, down 135.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19.7 million (down 214.6% YoY), and the FY2025 annual result was -$1.5 million, down 2211.59% from the prior year.
• Other Working Capital Changes came in at -$4.7 million for Q1 2026 at Corcept Therapeutics, down from -$2.9 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.5 million in Q1 2025 to a low of -$11.3 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is -$793000.0 (2025), against an average of -$177733.3.
• Across the five-year window, Other Working Capital Changes sank 1538.24% in 2022 and jumped 474.45% in 2025, its largest moves.
• Corcept Therapeutics' Other Working Capital Changes stood at $3.6 million in 2022, then dropped by 25.26% to $2.7 million in 2023, then soared by 216.2% to $8.5 million in 2024, then plunged by 133.95% to -$2.9 million in 2025, then sank by 63.54% to -$4.7 million in 2026.
• The last three Other Working Capital Changes figures came in at -$4.7 million (Q1 2026), -$2.9 million (Q4 2025), and -$793000.0 (Q3 2025), per Business Quant data.